AI and the future of pharmaceuticals
17
Sep 2025
17 Sep
02:30 → 04:00 PM
In-person event
Abu Dhabi
Hub71, 15th Floor, Al Khatem Tower
![Icon](https://hub71.morestaging.com/storage/media/5144/conversions/website-thumbnails-sep2025-1-converted-webp.webp?v=1760622450" width="1500" height="841" srcset="https://hub71.morestaging.com/storage/media/5144/responsive-images/website-thumbnails-sep2025-1___converted-webp_1500_841.webp 1500w, https://hub71.morestaging.com/storage/media/5144/responsive-images/website-thumbnails-sep2025-1___converted-webp_1254_703.webp 1254w, https://hub71.morestaging.com/storage/media/5144/responsive-images/website-thumbnails-sep2025-1___converted-webp_1050_589.webp 1050w, https://hub71.morestaging.com/storage/media/5144/responsive-images/website-thumbnails-sep2025-1___converted-webp_878_492.webp 878w)
AI is revolutionizing drug discovery — cutting timelines, reducing costs, and unlocking new frontiers in medicine. Insilico Medicine made history as the first company to advance an AI-discovered molecule into Phase II clinical trials with proven efficacy, showcasing the real-world impact of AI in pharmaceuticals.
Join Dr. Alex Aliper, President of Insilico Medicine, as he shares the company’s journey to unicorn status, its breakthrough AI platform, Pharma.AI, AI-powered robotics lab, and how Abu Dhabi’s innovation ecosystem is fueling global biotech success.